RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.
about
GDNF is a fast-acting potent inhibitor of alcohol consumption and relapseMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceGDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System FunctionGDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson diseasePro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neuronsIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceGlutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neuronsMotor neuron trophic factors: therapeutic use in ALS?Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalonParkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degenerationASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, geneCDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor.GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.Glial cell line-derived neurotrophic factor partially ameliorates motor symptoms without slowing neurodegeneration in mice with respiratory chain-deficient dopamine neurons.Use of growth factors for the treatment of Parkinson's disease.Neuroprotection by GDNF in the ischemic brain.Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.The Ret receptor regulates sensory neuron dendrite growth and integrin mediated adhesionEfficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor deliveryPegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system.Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease.Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice.Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
P2860
Q24658003-74D0A8C7-85F6-42EC-AFE0-B45411832F7EQ26773064-48D48B3B-1C8A-48E5-8EF5-AE0F0937D309Q27309907-C93B4C3E-953B-4969-8546-B03DEBCFEC36Q28083626-F2CA63C8-BA7B-497A-A5EE-2458CE1DB2EEQ28473591-792059BD-7BB8-4918-8FB5-36216DEC08B4Q28478469-7CBFC699-D0B7-403F-8249-390A2F691254Q30498761-2C89080C-AF9A-4132-A874-BCE978EDB802Q35027903-7D1745F7-B406-4BC6-83D6-6DF3B2ED6510Q35149520-AE7F3551-6366-489C-AE6A-4B4F8E527578Q36179023-5AE779E0-C54F-4F11-A17E-580FA97E755AQ36184308-228A27D1-C7E3-44CF-89EC-33787ECABCC9Q37097033-E1EF8328-FB83-4803-B843-68405E2F8A29Q37121244-BDF4ECB3-DEAF-4F8D-AD53-3D6D6FD698FDQ37462819-4FDB727F-372E-464E-BEF7-1F236F115083Q37462824-EC1C0202-F118-4939-AD0C-3162D2396D5AQ37466357-8853449A-CC76-4974-97A4-B36E4530309DQ37762259-85F3D8EE-E890-4A4D-AEC1-E23723FC5268Q38016480-E321FC1F-B468-426A-9706-91DC3F82EF24Q38747586-B0E4AD7A-B44C-48D5-BF0A-DF5633607249Q39154870-7BC48F09-F8FD-4621-846C-1D64489963DEQ39433861-1493C868-D358-4979-B0A3-366C4429F517Q39442534-8B7A5888-DBFE-46A0-BE24-4A07F03ED5EAQ39639495-D74F7DF5-7011-49B3-9E02-7838D6E55066Q39705421-6801ABEA-7239-49F1-99D9-12F743B766E2Q42722144-6366CC07-147D-4A14-86B1-3A185A945DAAQ48508627-796772F2-0741-440B-8786-59CDC44324D6Q48793100-AB0036A1-D2D7-4A3E-8904-1AA8F03896A4Q53064509-3A5FB6E8-421A-4AB1-AA1F-EDD457E7ED26
P2860
RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
RET signaling does not modulat ...... f dopaminergic axon terminals.
@ast
RET signaling does not modulat ...... f dopaminergic axon terminals.
@en
type
label
RET signaling does not modulat ...... f dopaminergic axon terminals.
@ast
RET signaling does not modulat ...... f dopaminergic axon terminals.
@en
prefLabel
RET signaling does not modulat ...... f dopaminergic axon terminals.
@ast
RET signaling does not modulat ...... f dopaminergic axon terminals.
@en
P2093
P2860
P50
P356
P1476
RET signaling does not modulat ...... of dopaminergic axon terminals
@en
P2093
Anja Kruse
Charlotte Pöppelmeyer
Sebastian Kowsky
P2860
P304
20049-20054
P356
10.1073/PNAS.0706177104
P407
P577
2007-12-04T00:00:00Z